|Targets||Toll-like Receptor (TLR)|
|Description||A potent and oral agonist of TLR7|
|B0084-473893||300 mg||$499||In stock|
|Brife Description||A potent and oral agonist of TLR7|
|Synonyms||4-amino-2-butoxy-8-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-5,7-dihydropteridin-6-one; GS-9620; GS9620; Vesatolimod|
|Solubility||Soluble in DMSO, not in water|
|Storage||Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).|
|Shelf Life||>2 years if stored properly|
An imidazoquinolinamine and TLR7 agonist with antitumor and antiviral activity; Phase I
FSL 1 is a TLR2/6 peptide agonist (also a putative TLR10 ligand) that activates NF-κB. FSL 1 induces the expression of some pro-inflammatory cytokines such as I...
Pam2CSK4 Biotin is the biotinylated Pam2CSK4. Pam2CSK4, a synthetic diacylated lipopeptide (LP), is a toll-like receptor 2/6 (TLR2/6) agonist, and induces TNF-α...
Agatolimod sodium selectively targets Toll-like receptor 9 (TLR9). It has potential antineoplastic and immunostimulatory activity and is used as an anticancer a...
A benzoazepine compound, an agonist of TLR7, analog of the TLR8 agonist VTX-233
Imiquimod maleate is an immune response modifier. It acts as a toll-like receptor 7 agonist. It is commonly used topically to treat warts on the skin of the gen...
TLR9 inhibitor; Autophagy inhibitor
A potent small-molecule agonist of TLR1/2(EC50 = 52.9 nM)
CU CPT 22
Selective TLR1/2 inhibitor(IC50 = 0.58 μM)
A small-molecule-specific inhibitor of TLR4 signaling,
CU-CPT-9a is a TLR8 antagonist with an IC50 of 0.5 nM.
Agonist of TLR9; An immunomodulating synthetic oligonucleotide; As a monotherapy and in combination with chemotherapeutic agents, and also as an adjuvant for va...
Polyadenylic acid-Polyuridylic acid sodi
An agonist of TLR7 with immune response modifying activity; Approved for basal cell carcinoma; In Phase III for VIN and CIN; Imiquimod's proapoptotic activity ...
Interferes with TLR4, TLR2/6 signaling; Orally active immunomodulatory agent; Inhibits TNF-α secretion via interference of macrophage TLR4 and TLR 2/6 signaling...
CU-CPT-9m is a TLR8 antagonist with an IC50 of 67 nM.
An agonist of TLR7
CPG52364 sulfate is the sulfate form of CPG52364, which is a small molecule toll-like receptor(TLR) antagonist. It has recently completed phase 1 clinical trial...
AL-034 is a Toll-like receptor 7 (TLR7) agonist in a phase I clinical trial for the treatment of HBV infections.
A small-molecule agonist of TLR7